Morgan, T. M., Pitts, T. E., Gross, T. S., Poliachik, S. L., Vessella, R. L., & Corey, E. (2008). RAD001 (Everolimus) Inhibits Growth of Prostate Cancer in the Bone and the Inhibitory Effects Are Increased by Combination With Docetaxel and Zoledronic Acid.
Citação norma ChicagoMorgan, Todd M., Tiffany E.M Pitts, Ted S. Gross, Sandra L. Poliachik, Robert L. Vessella, and Eva Corey. RAD001 (Everolimus) Inhibits Growth of Prostate Cancer in the Bone and the Inhibitory Effects Are Increased By Combination With Docetaxel and Zoledronic Acid. 2008.
Citação norma MLAMorgan, Todd M., et al. RAD001 (Everolimus) Inhibits Growth of Prostate Cancer in the Bone and the Inhibitory Effects Are Increased By Combination With Docetaxel and Zoledronic Acid. 2008.